WithdrawnPhase 2NCT01769027

Antibiotic Treatment and Intravenous Immunoglobulin Trial for PANDAS

Studying PANDAS

Last synced from ClinicalTrials.gov April 1, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: CNS Onlus
Principal Investigator: Stefano Pallanti, MD; PhD
Intervention: Sertraline+Antibiotic (penicillin/azithromycin)(drug)
Eligibility: 4-40 years · All sexes
Timeline: 2013 – 2016

Collaborators

University of Florence

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01769027 on ClinicalTrials.gov

Other trials for PANDAS

Additional recruiting or active studies for the same condition.

RECRUITINGNCT06811935
PEDI Pediatric Autoimmune Neuropsychiatric Disorder Associated With Streptococcus Study
University of Wisconsin, Madison
RECRUITINGNCT02889016
Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS
Stanford University

See all trials for PANDAS →

← Back to all trials